GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Share-based Compensation of $35.0 million for Q1 2026, down 60.67% on a QoQ basis from $89.0 million in Q4 2025, and up 59.09% year-over-year from $22.0 million in Q1 2025.
GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Share-based Compensation history runs 5 years deep, the most recent figure standing at $35.0 million for Q1 2026.
- Quarterly Share-based Compensation rose 59.09% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.0 million (up 26.55% YoY) and the FY2025 annual result came in at $130.0 million, up 4.0% from the prior year.
- Share-based Compensation was $35.0 million for Q1 2026 at GE HealthCare Technologies, down from $89.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $89.0 million in Q4 2025 and bottomed at -$58.0 million in Q4 2022.
- A 5-year average of $23.8 million and a median of $24.0 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation slumped 210.53% — and 2024, when it surged 309.52%.
- GE HealthCare Technologies' Share-based Compensation stood at -$58.0 million in 2022, then soared by 243.1% to $83.0 million in 2023, then tumbled by 60.24% to $33.0 million in 2024, then soared by 169.7% to $89.0 million in 2025, then tumbled by 60.67% to $35.0 million in 2026.
- Business Quant data shows GEHC's Share-based Compensation at $35.0 million in Q1 2026, $89.0 million in Q4 2025, and -$15.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 12.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 89.00 Mn |
| Dec 31, 2025 | 89.00 Mn |
| Sep 30, 2025 | -15.00 Mn |
| Sep 30, 2025 | -15.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Jun 30, 2025 | 34.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 33.00 Mn |
| Dec 31, 2024 | 33.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Dec 31, 2023 | 83.00 Mn |
| Dec 31, 2023 | 83.00 Mn |